Roche posted higher-than-expected first-quarter sales, driven by robust demand for its key drugs, as the company takes active ...

Telangana Anti Narcotics Bureau apprehended Ezeonyili Franklin Uchenna, a Nigerian drug supplier, in Hyderabad after he had ...

Bristol Myers Squibb Co.’s treatment for schizophrenia failed in a study designed to expand its use, denting the company’s ...

BPaL/M is a six-month all-oral regimen recommended by the World Health Organization (WHO) to treat most forms of ...

Imagine materials that build themselves, responding intelligently to their environment to deliver drugs precisely where ...

Guernsey County Sheriff Jeff Paden announced significant prison sentences for three individuals involved in high-level drug ...

Swiss pharma giant Roche Holding AG RHHBY posted strong growth in the first quarter of 2025. Sales increased 7% year over year to CHF 15.4 billion and were up 6% at constant exchange rates (CER).

Roche posted higher-than-expected first-quarter sales, driven by robust demand for its key drugs, as the company takes active steps to preempt looming U.S. import tariffs. To strengthen its U.S ...

Roche posted higher first-quarter sales that beat analysts' expectations on higher demand for its key drugs. The Swiss pharmaceutical giant said Thursday that sales rose to 15.44 billion Swiss ...

A new executive order signed Tuesday by President Trump directs Congress to change a key provision of the law allowing ...

Researchers at the VIB-UGent Center for Medical Biotechnology have discovered a promising strategy to improve treatment ...